Abilify - Aripiprazole
4 customer reviewsAbilify is an atypical antipsychotic medicine containing aripiprazole. It is used for schizophrenia, bipolar disorder, and as an add-on treatment for depression. It helps stabilise mood and behaviour by modulating dopamine and serotonin signalling.
What is it?
Abilify, with the active ingredient aripiprazole, is an atypical antipsychotic medicine used to treat schizophrenia and bipolar disorder, and it can be added to antidepressants in major depressive disorder. It is used in adults (and in some indications, adolescents) who need help with symptoms like hallucinations, delusions, severe mood swings, agitation, or persistent depression despite standard treatment. Aripiprazole works by modulating dopamine and serotonin signalling to stabilise thought, mood, and behaviour. [1]
In everyday psychiatric prescribing, Abilify is most commonly used for:
- Schizophrenia: to reduce positive symptoms (hallucinations, delusions, thought disorganisation) and help prevent relapse.
- Bipolar I disorder: for acute manic or mixed episodes, and in some cases for ongoing mood stabilisation.
- Major depressive disorder (adjunct use): added to an antidepressant when depression has not responded well enough.
- Irritability associated with autism spectrum disorder: to reduce severe irritability and aggression (used in specific age groups under specialist direction).
One practical advantage: Abilify is often less sedating than some antipsychotics, so people who need to stay functional during the day may find it easier to tolerate. A drawback is that activation or akathisia can be hard to ignore.
Composition
Abilify contains aripiprazole as the active substance. The tablets also include standard excipients that help with stability, tablet formation, and absorption, such as fillers, binders, and disintegrants. It is an oral antipsychotic medicine used under medical supervision.
How to use?
Abilify is an oral antipsychotic medicine taken by mouth, usually once daily, with or without food. The dose is individualized based on the condition treated, age, other medicines, and tolerability.
Typical dosing patterns used in practice:
- Schizophrenia in adults: often starts at 10–15 mg once daily.
- Bipolar mania in adults: often starts at 15 mg once daily.
- Adjunct treatment of depression in adults: often starts at 2–5 mg once daily and is increased cautiously.
Take the tablet at the same time each day and follow the prescribed schedule exactly. If sleep problems or restlessness appear, a clinician may adjust the timing or the dose.
How does it work?
- Route: oral tablets swallowed whole with water.
- Frequency: usually once daily.
- Timing: take at the same time each day; may be taken with or without food.
- Adult schizophrenia dose: 10–15 mg/day by mouth.
- Adult bipolar mania dose: 15 mg/day by mouth.
- Adjunct depression dose: start at 2–5 mg/day by mouth, then adjust as directed.
- Duration: use for the full period prescribed by the physician; do not stop suddenly without medical advice.
Indications
Abilify belongs to atypical antipsychotic medications. “Atypical” means it tends to affect dopamine and serotonin in a more balanced way than older antipsychotic drugs, which can translate into a different side-effect pattern for some people.
In everyday psychiatric prescribing, Abilify is most commonly used for:
- Schizophrenia: to reduce positive symptoms (hallucinations, delusions, thought disorganisation) and help prevent relapse.
- Bipolar I disorder: for acute manic or mixed episodes, and in some cases for ongoing mood stabilisation.
- Major depressive disorder (adjunct use): added to an antidepressant when depression has not responded well enough.
- Irritability associated with autism spectrum disorder: to reduce severe irritability and aggression (used in specific age groups under specialist direction).
One practical advantage: Abilify is often less sedating than some antipsychotics, so people who need to stay functional during the day may find it easier to tolerate. A drawback is that activation or akathisia can be hard to ignore.
Comparison
Abilify sits within atypical antipsychotic medications, and its receptor profile often makes it feel different day-to-day than more sedating or more strongly dopamine-blocking choices.
| Option (active ingredient) | How it tends to feel | Trade-offs |
|---|---|---|
| Aripiprazole (Abilify) | Often more activating; can help drive and cognition in some | Higher chance of akathisia/restlessness for some people |
| Olanzapine | Often calming; strong antimanic effect | Weight gain and metabolic effects can be significant |
| Risperidone | Strong antipsychotic effects; useful for agitation | Prolactin elevation and EPS can be limiting in some |
Doctors pick between these based on the symptom target (mania vs psychosis vs depression adjunct), patient history (weight, diabetes risk, movement side effects), and whether daytime alertness matters for work and driving.
Contraindications
Despite its effectiveness, Abilify has a number of contraindications that must be taken into account before starting therapy. The drug may be unsafe for some categories of patients, and its use should be carried out under strict medical supervision.- Hypersensitivity or allergy to aripiprazole or any other components of the drug.
- Serious cardiovascular diseases, including uncontrolled arrhythmia, since the drug can cause changes in heart rate.
- Severe liver or kidney disease, which can affect the metabolism and elimination of the drug from the body.
- Conditions associated with an increased risk of seizures, such as epilepsy, since Abilify can increase the likelihood of seizures.
- Pregnancy and breastfeeding, since the effect of the drug on the development of the fetus and newborn has not been sufficiently studied.
Not recommended for
Abilify may not be a good fit if you need a medicine that makes you sleepy, or if you already struggle with feeling restless, keyed up, or unable to sit still. It also needs extra caution if you are sensitive to movement side effects, dizziness, or changes in blood sugar and weight.
Side effects
Abilify’s potential side effects range from mild and time-limited to rare but serious. Many effects are most noticeable in the first few weeks, then settle.
Commonly reported side effects in practice include:
- Nausea, stomach upset
- Insomnia or lighter sleep
- Dizziness (sometimes linked to blood pressure changes)
- Weight gain in some people
- Restlessness (akathisia), feeling unable to sit still
- Tremor or other involuntary movements (less common, more likely with long-term exposure)
Serious reactions to recognise early:
- Extrapyramidal symptoms (EPS): stiffness, tremor, slowed movements, inner restlessness.
- Tardive dyskinesia: repetitive involuntary movements (often mouth/tongue). Risk rises with duration and cumulative exposure.
- Neuroleptic malignant syndrome (NMS): fever, severe rigidity, confusion, autonomic instability. This is an emergency.
- Metabolic changes: increases in blood sugar or lipids can occur even without obvious weight gain.
Three short points matter. Side effects can be dose-related. Timing can fix a lot.
Doctor opinions
Doctors usually view Abilify as a useful antipsychotic when symptom control is needed with a lower risk of heavy sedation than some alternatives. They often stress steady daily use, since missed doses can reduce benefit and trigger symptom return. Patients should contact a physician promptly if restlessness, insomnia, mood changes, or worsening psychiatric symptoms appear.
Frequently asked questions
Some effects (less agitation, clearer thinking, improved sleep pattern) can show up in the first 1–2 weeks, while full antipsychotic or mood-stabilising benefit often takes several weeks of steady dosing. The timeline also depends on what it’s treating: mania can respond faster than negative symptoms of schizophrenia. If Abilify is added for depression, clinicians usually look for change across 2–6 weeks while titrating carefully. This aligns with patient information and clinical evidence reviewed by the EMA in 2024. [4]
Weight gain is possible on Abilify, but the risk is often lower than with some other atypical antipsychotics. The tricky part is that appetite can rise quietly, and even a small daily increase adds up over months. Clinicians usually monitor weight, waist size, and blood tests (glucose and lipids) because metabolic changes can occur even without dramatic weight gain. Guidance used by services following WHO mental health medicine principles emphasises regular physical health monitoring during antipsychotic treatment. [5]
Abilify can cause insomnia in some people, and it can cause sleepiness in others. Dose timing is a common fix: people who feel activated often do better with morning dosing, while people who feel drowsy may be advised to take it later in the day. Caffeine, pre-workout stimulants, and nicotine can amplify insomnia, so reviewing stimulant intake is part of the plan. Persistent insomnia after a schedule change is a reason to reassess dose or the in total regimen.
Alcohol can worsen dizziness, impaired coordination, and judgement, and it can destabilise mood symptoms that Abilify is being used to treat. Some people feel “fine” after one drink, then realise the next day that sleep and irritability were affected. If alcohol use is regular, prescribers often plan dosing and monitoring around it, since relapse risk rises when sleep and routine are disrupted. For people taking Abilify as an adjunct in depression, alcohol can also blunt antidepressant response.
Planning matters here. Antipsychotic exposure in late pregnancy can be linked with neonatal adaptation symptoms, so the prescribing team usually reviews dose, benefits, and alternatives before the third trimester when possible. Breastfeeding decisions depend on the balance between maternal stability and infant exposure, plus the availability of support at home. MOHAP-aligned care pathways in the UAE typically prioritise coordinated obstetric and psychiatric follow-up when psychotropic medicines are continued in pregnancy.
EPS is a group of movement-related side effects that can include stiffness, tremor, slowed movement, and akathisia. Tardive dyskinesia is different: it tends to be delayed and can persist even after stopping, which is why routine screening is used in long-term treatment. Early reporting helps, since dose adjustment or switching strategy can prevent progression. If you notice new jaw, tongue, or lip movements, treat it as urgent follow-up rather than a wait-and-see issue.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Abilify — Comparison with alternatives
Abilify Current
Haldol
Risperdal Best rated
Solian
Olanzapine Best price
Reviews and Experiences
Sources
- U.S. Food and Drug Administration (FDA) (2023). ABILIFY (aripiprazole) — Prescribing Information. ↑
- European Medicines Agency (EMA) (2024). Aripiprazole — Summary of Product Characteristics (SmPC). ↑
- National Pregnancy Registry for Atypical Antipsychotics (2025). Registry Overview and Patient Information for Atypical Antipsychotic Exposure in Pregnancy. ↑
- National Institute for Health and Care Excellence (NICE) (2025). Psychosis and schizophrenia in adults: prevention and management — guideline (current update). ↑
- World Health Organization (WHO) (2025). Management of physical health conditions in adults with severe mental disorders — guidance relevant to antipsychotic monitoring. ↑